TotalMarketCap

Mirum Pharmaceuticals

MIRMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$6.112 B

$93.62 -3.45%

Close of 6 Nov 2026

As of 6 Nov 2026, Mirum Pharmaceuticals (MIRM) has a market capitalization of $6.11B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$521.3M

#1871 by revenue

Earnings

-$23.4M

Loss-making

Shares outstanding

65,282,044

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #46Amneal PharmaceuticalsAMRX$6.78B
  2. #47Ionis PharmaceuticalsIONS$6.43B
  3. #48Mirum PharmaceuticalsMIRM$6.11B
  4. #49Ligand PharmaceuticalsLGND$5.95B
  5. #50GrifolsGRFS$5.85B

What if Mirum Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$432,536.61

Per share 4,620× higher

Bitcoin $1.53T

$23,403.80

Per share 250× higher

Apple $5.02T

$76,832.50

Per share 821× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Mirum Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.